BRUSSELS (Reuters) - The European Union reached a deal with Pfizer and BioNTech for 300 million additional doses of their COVID-19 vaccine, the head of the European Commission said on Friday, in a ...

Pfizer shares tumbled again Monday, continuing the pharmaceutical giant’s struggles tied to declining demand for its Covid-19 products and essentially wiping out the entirety of the firm’s peak ...

Add Yahoo as a preferred source to see more of our stories on Google. Pfizer told pharmacies and clinics this week it will soon price a five-day course of COVID-19 treatment Paxlovid at almost $1,400, ...

NEW YORK, NEW YORK - MAY 22: Dr. Albert Bourla, Chairman and CEO, Pfizer speaks onstage during The Wall Street Journal's 2024 The Future Of Everything Festival at Spring Studios on May 22, 2024 in New ...

Pfizer is an over-100-year-old drug company going through a rough patch, which has happened before.

Pfizer stock (NYSE: PFE) currently trades at $28 per share, 55% below its peak level of $61 seen in December 2021. In contrast, Merck stock (NYSE:MRK) is up 36% over this period. PFE stock was trading ...